- Home
- NISN vs CGTX Comparison
NISN vs CGTX Comparison
Compare NISN & CGTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NISN
- CGTX
- Stock Information
- Founded
- NISN 2005
- CGTX 2007
- Country
- NISN China
- CGTX United States
- Employees
- NISN N/A
- CGTX N/A
- Industry
- NISN Metal Fabrications
- CGTX Biotechnology: Pharmaceutical Preparations
- Sector
- NISN Industrials
- CGTX Health Care
- Exchange
- NISN Nasdaq
- CGTX Nasdaq
- Market Cap
- NISN 23.5M
- CGTX 20.5M
- IPO Year
- NISN 2016
- CGTX 2021
- Fundamental
- Price
- NISN $3.36
- CGTX $0.26
- Analyst Decision
- NISN
- CGTX Strong Buy
- Analyst Count
- NISN 0
- CGTX 5
- Target Price
- NISN N/A
- CGTX $5.63
- AVG Volume (30 Days)
- NISN 57.7K
- CGTX 1.8M
- Earning Date
- NISN 04-29-2025
- CGTX 08-07-2025
- Dividend Yield
- NISN N/A
- CGTX N/A
- EPS Growth
- NISN N/A
- CGTX N/A
- EPS
- NISN 1.43
- CGTX N/A
- Revenue
- NISN $340,219,546.00
- CGTX N/A
- Revenue This Year
- NISN N/A
- CGTX N/A
- Revenue Next Year
- NISN N/A
- CGTX N/A
- P/E Ratio
- NISN $14.76
- CGTX N/A
- Revenue Growth
- NISN 8.05
- CGTX N/A
- 52 Week Low
- NISN $3.14
- CGTX $0.22
- 52 Week High
- NISN $22.55
- CGTX $2.54
- Technical
- Relative Strength Index (RSI)
- NISN 33.74
- CGTX 37.68
- Support Level
- NISN $3.40
- CGTX $0.29
- Resistance Level
- NISN $3.97
- CGTX $0.32
- Average True Range (ATR)
- NISN 0.41
- CGTX 0.03
- MACD
- NISN -0.05
- CGTX 0.00
- Stochastic Oscillator
- NISN 4.08
- CGTX 12.50
About NISN NiSun International Enterprise Development Group Co. Ltd.
NiSun International Enterprise Development Group Co Ltd is a provider of supply chain solutions and integrated financial services. Nisun is dedicated to providing professional supply chain solutions to Chinese and foreign enterprises and financial institutions. Through its subsidiaries, it is engaged in delivering supply chain solutions, and supply chain trading services to its customers across different industries. The company also provides financial solutions to small and mid-sized enterprises within the supply chain ecosystem. Using its fintech platforms, it provides various financing options, including supply chain financing, trade financing, and receivables financing. Geographically, its operations are predominantly focused on markets within the People's Republic of China.
About CGTX Cognition Therapeutics Inc.
Cognition Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of, small-molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its product candidate CT1812, is an orally delivered, small-molecule antagonist designed to penetrate the blood-brain barrier and bind selectively to the S2R complex.